StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ascendis Pharma A/S
NasdaqGS:ASND
Sector
Location
Market Cap
USD 10.54 B
Share Price
USD 174.18
Avg Daily Volume
505,371
Change (1 day)
0.62%
Change (1 year)
29.81%
Change (YTD)
26.52%
Ascendis Pharma A/S Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2024: USD -329.83 M
Ascendis Pharma A/S Free Cash Flow is USD -329.83 M for the Trailing 12 Months (TTM) ending December 31, 2024, a -35.06% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Ascendis Pharma A/S Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -507.87 M, a -5.76% change year over year.
-
Ascendis Pharma A/S Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -538.88 M, a 4.90% change year over year.
-
Ascendis Pharma A/S Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -513.71 M, a 51.00% change year over year.
-
Ascendis Pharma A/S Free Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -340.21 M, a 69.01% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Torrent Pharmaceuticals Limited
USD 39.40
TORNTPHARM.NS
+0.37
0.96%
Regencell Bioscience Holdings Limited
USD 22.99
RGC
+12.63
121.91%
Laurus Labs Limited
USD 9.08
LAURUSLABS.NS
+0.20
2.24%
ADMA Biologics, Inc.
USD 18.28
ADMA
+0.14
0.77%
Ipca Laboratories Limited
USD 16.64
IPCALAB.NS
+0.07
0.44%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.09
002603.SZ
+0.00
0.04%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.63
600566.SS
-0.01
-0.31%
Pfizer Limited
USD 67.66
PFIZER.NS
-0.03
-0.04%
BGI Genomics Co., Ltd.
USD 6.86
300676.SZ
-0.00
-0.01%
Eris Lifesciences Limited
USD 19.96
ERIS.NS
-0.15
-0.75%
Hybio Pharmaceutical Co., Ltd.
USD 2.58
300199.SZ
+0.04
1.74%
Liaoning Cheng Da Co., Ltd.
USD 1.54
600739.SS
-0.00
-0.06%
Vimian Group AB (publ)
USD 4.36
VIMIAN.ST
-0.00
-0.09%
NovoCure Limited
USD 17.71
NVCR
-0.17
-0.95%
Harmony Biosciences Holdings, Inc.
USD 32.16
HRMY
+0.05
0.16%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.08
002020.SZ
+0.19
10.06%
Tibet Cheezheng Tibetan Medicine Co., Ltd.
USD 3.16
002287.SZ
-0.02
-0.75%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 76.07
GEHC
-0.05
-0.07%
Laboratory Corporation of America Holdings
USD 261.89
LH
+1.89
0.73%
Torrent Pharmaceuticals Limited
USD 39.40
TORNTPHARM.NS
+0.37
0.96%
Regencell Bioscience Holdings Limited
USD 22.99
RGC
+12.63
121.91%
Laurus Labs Limited
USD 9.08
LAURUSLABS.NS
+0.20
2.24%
ADMA Biologics, Inc.
USD 18.28
ADMA
+0.14
0.77%
Ipca Laboratories Limited
USD 16.64
IPCALAB.NS
+0.07
0.44%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.09
002603.SZ
+0.00
0.04%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.63
600566.SS
-0.01
-0.31%
Pfizer Limited
USD 67.66
PFIZER.NS
-0.03
-0.04%
BGI Genomics Co., Ltd.
USD 6.86
300676.SZ
-0.00
-0.01%
Eris Lifesciences Limited
USD 19.96
ERIS.NS
-0.15
-0.75%
Hybio Pharmaceutical Co., Ltd.
USD 2.58
300199.SZ
+0.04
1.74%
Liaoning Cheng Da Co., Ltd.
USD 1.54
600739.SS
-0.00
-0.06%
Vimian Group AB (publ)
USD 4.36
VIMIAN.ST
-0.00
-0.09%
NovoCure Limited
USD 17.71
NVCR
-0.17
-0.95%
Harmony Biosciences Holdings, Inc.
USD 32.16
HRMY
+0.05
0.16%
Adaptive Biotechnologies Corporation
USD 11.80
ADPT
+0.32
2.79%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.08
002020.SZ
+0.19
10.06%
Tibet Cheezheng Tibetan Medicine Co., Ltd.
USD 3.16
002287.SZ
-0.02
-0.75%